Pretreatment with oxygen protects rat kidney from cisplatin nephrotoxicity

Renal Failure

Volumn 32, Issue 2, 2010, Pages 234-242

  Rasoulian, Bahram ^a   Jafari, Mahvash ^b   Mahbod, Mirgholamreza ^c   Dehaj, Mansour Esmaili ^d   Nowrozi, Majid ^b   Wahhabaghai, Hannaneh ^e   Mofid, Mahmood ^b   Ghasemi, Asghar ^f   Bigdeli, Mohammad Reza ^g   Khoshbaten, Ali ^d  

^a LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SHAHID BEHESHTI UNIVERSITY   (Iran)

Author keywords

Acute renal failure; Catalase; Cisplatin; Nephrotoxicity; Oxygen

Indexed keywords

CISPLATIN; CREATININE; OXYGEN; UREA;

AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; KIDNEY FUNCTION; KIDNEY HEMORRHAGE; KIDNEY PARENCHYMA; KIDNEY TUBULE NECROSIS; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL PROTECTION;

ANIMALS; BIOLOGICAL MARKERS; CISPLATIN; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MAGNESIUM; MALE; OXYGEN; RATS; RATS, WISTAR; STATISTICS, NONPARAMETRIC;

EID: 77749297947     PISSN: 0886022X     EISSN: 15256049     Source Type: Journal    
DOI: 10.3109/08860221003592838     Document Type: Article

References (43)

1. Livingston RB. Cisplatin in the treatment of solid tumors: Effect of dose and schedule. J Natl Cancer Inst. 1989 May 10;81(10):724-725.
2. Arany I, Safirstein RL. Cisplatin nephrotoxicity. Semin Nephrol. 2003 Sep; 23(5):460-464.
3. Berns JS, Ford PA. Renal toxicities of antineoplastic drugs and bone marrow transplantation. Semin Nephrol. 1997 Jan; 17(1):54-66.
4. Santoso JT, Lucci JA III, Coleman RL, Schafer I, Hannigan EV. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: A randomized trial. Cancer Chemother Pharmacol. 2003 Jul; 52(1):13-18.
5. Taguchi T, Nazneen A, Abid MR, Razzaque MS. Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol. 2005;148:107-121.
6. Bonventre JV. Kidney ischemic preconditioning. Curr Opin Nephrol Hypertens. 2002 Jan; 11(1):43-48.
7. Mohammadhosseiniakbari H, Rasoulian B, Noroozzadeh A, et al. The effect of short ischemic periods in reducing subsequent rat renal ischemic injury. Physiology and Pharmacology. 2008;12(2):149-157 [in Persian].
8. Torras J, Herrero-Fresneda I, Lloberas N, Riera M, Ma CJ, Ma GJ. Promising effects of ischemic preconditioning in renal transplantation. Kidney Int. 2002 Jun;61(6):2218-2227.
9. Rasoulian B, Mohammadhosseniakbari H, Kadkhodaee M, et al. Preconditioning with oxygen attenuates rat renal ischemia-reperfusion injury. J Surg Res. 2008 May 15;146(2):282-288.
10. Cetin R, Devrim E, Kilicoglu B, Avci A, Candir O, Durak I. Cisplatin impairs antioxidant system and causes oxidation in rat kidney tissues: Possible protective roles of natural antiox-idant foods. J Appl Toxicol. 2006 Jan; 26(1):42-46.
11. Tahepold P, Valen G, Starkopf J, Kairane C, Zilmer M, Vaage J. Pretreating rats with hyperoxia attenuates ischemia-reperfusion injury of the heart. Life Sci. 2001 Feb 23;68(14): 1629-1640.
12. Tinits P. Oxygen therapy and oxygen toxicity. Ann Emerg Med. 1983 May; 12(5):321-328.
13. Shimeda Y, Hirotani Y, Akimoto Y, et al. Protective effects of capsaicin against cisplatin-induced nephrotoxicity in rats. Biological and Pharmaceutical Bulletin. 2005 Sep; 28(9):1635-1638.
14. Behling EB, Sendao MC, Francescato HD, Antunes LM, Costa RS, Bianchi Mde L. Comparative study of multiple dosage of quercetin against cisplatin-induced nephrotoxicity and oxidative stress in rat kidneys. Pharmacol Rep. 2006 Jul-Aug;58(4):526-532.
15. Cohen G, Dembiec D, Marcus J. Measurement of catalase activity in tissue extracts. Anal Biochem. 1970 Mar; 34:30-38.
16. Paoletti F, Mocali A. Determination of superoxide dismutase activity by purely chemical system based on NAD(P)H oxidation. Methods Enzymol. 1990;186:209-220.
17. Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: Applications to mammalian blood and other tissues. Anal Biochem. 1969 Mar; 27(3):502-522.
18. Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin Chim Acta. 1978 Nov 15;90(1):37-43.
19. Bradford MM. A rapid and sensitive method for the quanti-tation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem. 1976 May 7; 72:248-254.
20. Solez K, Kramer EC, Fox JA, Heptinstall RH. Medullary plasma flow and intravascular leukocyte accumulation in acute renal failure. Kidney Int. 1974 Jul;6(1):24-37.
21. Matsushima H, Yonemura K, Ohishi K, Hishida A. The role of oxygen free radicals in cisplatin-induced acute renal failure in rats. J Lab Clin Med. 1998 Jun;131(6):518-526.
22. Ali BH, Al Moundhri MS. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: A review of some recent research. Food Chem Toxicol. 2006 Aug;44(8):1173-1183.
23. Appenroth D, Winnefeld K, Schroter H, Rost M. Beneficial effect of acetylcysteine on cisplatin nephrotoxicity in rats. J Appl Toxicol. 1993;13(3):189-192.
24. Sheikh-Hamad D, Timmins K, Jalali Z. Cisplatin-induced renal toxicity: Possible reversal by N-acetylcysteine. J Am Soc Nephrol. 1997 Oct;8(10):1640-1645.
25. Nisar S, Feinfeld DA. N-acetylcysteine as salvage therapy for cisplatin nephrotoxicity. Ren Fail. 2002 Jul; 24(4): 529-533.
26. Ajith TA, Jose N, Janardhanan KK. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus. J Exp Clin Cancer Res. 2002 Jun;21(2):213-217.
27. Bergendi L, Benes L, Durackova Z, Ferencik M. Chemistry, physiology and pathology of free radicals. Life Sci. 1999; 65(18-19):1865-1874.
28. Bougle D, Vert P, Reichart E, Hartemann D, Heng E. Retinal superoxide dismutase activity in newborn kittens exposed to normobaric hyperoxia effect of vitamin E. Pediatric Research. 1982;16(5):400.
29. Bigdeli MR, Hajizadeh S, Froozandeh M, et al. Normobaric hyperoxia induces ischemic tolerance and upregulation of glutamate transporters in the rat brain and serum TNF-alpha level. Exp Neurol. 2008 Aug;212(2):298-306.
30. Esmaili Dehaj M, Baharvand B, Rasoulian B, et al. Delayed protective effects of hyperoxia against cardiac arrhythmias and infarction in anesthetized rats. J Surg Res. 2009 Jan; 151(1):55-61.
31. Dong H, Xiong L, Zhu Z, Chen S, Hou L, Sakabe T. Preconditioning with hyperbaric oxygen and hyperoxia induces tolerance against spinal cord ischemia in rabbits. Anesthesiology. 2002 Apr;96(4):907-912.
32. Atasoyu EM, Yildiz S, Bilgi O, et al. Investigation of the role of hyperbaric oxygen therapy in cisplatin-induced nephro-toxicity in rats. Arch Toxicol. 2005 May;79(5):289-293.
33. Greeger R, Windhorst U. Comprehensive human physiology. 1st ed. Berlin, Heidelberg: Springer-Verlag; 1996.
34. Aydinoz S, Uzun G, Cermik H, et al. Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotox-icity. Ren Fail. 2007;29(3):257-263.
35. Vera G, Chiarlone A, Cabezos PA, Pascual D, Martin MI, Abalo R. WIN 55,212-2 prevents mechanical allodynia but not alterations in feeding behaviour induced by chronic cisplatin in the rat. Life Sci. 2007 Jul 19;81(6): 468-479.
36. Kim SH, Hong KO, Hwang JK, Park K-K. Xanthorrhizol has a potential to attenuate the high dose cisplatin-induced neph-rotoxicity in mice. Food and Chemical Toxicology. 2005 Jan;43(1):117-122.
37. Yu YN, Chen H, Li Y. Protect effect of bicyclol on cisplatin-induced nephrotoxicity in mice. Arch Toxicol. 2009 Apr; 83(4):381-387.
38. Tüközkan N, Erdamar H, Seven I, Anabilim GT, Dal A. Measurement of total malondialdehyde in plasma and tissues by high-performance liquid chromatography and thiobarbituric acid assay. Firat Tip Dergisi. 2006;11: 88-92.
39. Gaedeke J, Fels LM, Bokemeyer C, Mengs U, Stolte H, Lentzen H. Cisplatin nephrotoxicity and protection by silibinin. Nephrol Dial Transplant. 1996 Jan;11(1):55-62.
40. Teicher BA, Lazo JS, Sartorelli AC. Classification of antineo-plastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells. Cancer Res. 1981 Jan;41(1):73-81.
41. Alagoz T, Buller RE, Anderson B, et al. Evaluation of hyper-baric oxygen as a chemosensitizer in the treatment of epithelial ovarian cancer in xenografts in mice. Cancer. 1995 May 1;75(9):2313-2322.
42. Cannizzaro A, Verga Falzacappa CV, Martinelli M, Misiti S, Brunetti E, Bucci B. O(2/3) exposure inhibits cell progression affecting cyclin B1/cdk1 activity in SK-N-SH while induces apoptosis in SK-N-DZ neuroblastoma cells. J Cell Physiol. 2007 Oct;213(1):115-125.
43. Stogner SW, Payne DK. Oxygen toxicity. Ann Pharmacother. 1992 Dec;26(12):1554-1562.